BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19328410)

  • 1. Regulatory T cells: key players in tolerance and autoimmunity.
    Chatila TA
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):265-72, vii. PubMed ID: 19328410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of regulatory T-cell development.
    Chatila T
    Chem Immunol Allergy; 2008; 94():16-28. PubMed ID: 18802333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Plasticity of Regulatory T Cells in Health and Autoimmunity.
    Carbone F; Colamatteo A; La Rocca C; Lepore MT; Russo C; De Rosa G; Matarese A; Procaccini C; Matarese G
    J Immunol; 2024 Jun; 212(12):1859-1866. PubMed ID: 38830147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer.
    Kurniawan H; Soriano-Baguet L; Brenner D
    Eur J Immunol; 2020 Nov; 50(11):1626-1642. PubMed ID: 33067808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
    Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
    Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory dendritic cells in autoimmunity: A comprehensive review.
    Liu J; Cao X
    J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells in health and disease.
    Rouse BT
    J Intern Med; 2007 Jul; 262(1):78-95. PubMed ID: 17598816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking regulatory T cells into medicine.
    Sakaguchi S
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 34037676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulatory T cells - a possible promising target in the treatment of autoimmune diseases].
    Enghard P; Riemekasten G
    Z Rheumatol; 2003 Aug; 62(4):355-60. PubMed ID: 12928939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells: a review.
    Dasgupta A; Saxena R
    Natl Med J India; 2012; 25(6):341-51. PubMed ID: 23998865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases.
    Zhang A; Qu Y; Zhang B; Zhang L; Zeng C; Peng J; Ji X; Hou M; Zhao Y
    J Mol Med (Berl); 2007 Nov; 85(11):1263-70. PubMed ID: 17639287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trends with FOXP3
    Trinath J; Bayry J
    Immunotherapy; 2019 Jun; 11(9):755-758. PubMed ID: 31094264
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.
    von Boehmer H; Daniel C
    Nat Rev Drug Discov; 2013 Jan; 12(1):51-63. PubMed ID: 23274471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial overview: Autoimmunity.
    Anderson MS; Mackay F
    Curr Opin Immunol; 2015 Dec; 37():v-vii. PubMed ID: 26510378
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-negative regulatory T cells: non-conventional regulators.
    Thomson CW; Lee BP; Zhang L
    Immunol Res; 2006; 35(1-2):163-78. PubMed ID: 17003518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.